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Background
The use of iodinated contrast media (CM) is commonly
associated with hypersensitivity reactions. However, the
management of hypersensitivity reactions is not well
established especially for delayed hypersensitivity reac-
tions (DHRs). We report a case of CM associated sys-
temic hypersensitivity where selection of a structurally




A 78-year-old female with end stage renal disease on
hemodialysis via arteriovenous fistula, diabetes mellitus,
hypertension, and hyperlipidemia was evaluated for
recurrent fever and rash after receiving CM for a fistulo-
gram. She had received prednisone prophylactically for
reactions associated with ioxilan administration on two
prior fistulograms. These reactions consisted of diffuse
erythematous rash preceded by fever that started
2-4 hours after contrast administration and lasted several
days. After receiving pretreatment with prednisone and
diphenhydramine, she received her most recent dose of
ioxilan (70 mL) for a fistulogram and developed fever
and diffuse erythematous rash (2 and 4 hours post injec-
tion, respectively). The fever lasted 3 days and the rash
subsequently desquamated involving the arms, trunk,
neck and face. Her skin fully re-epithelialized 2 weeks
later. She had negative skin prick tests and negative patch
tests to ioxilan, iothalamate, and iohexol. She subse-
quently underwent challenge with 10 mL of intravenous
iothalamate and was observed for 4 hours without inci-
dent. Later, she underwent fistulogram with iothalamate
and tolerated it without adverse reactions.
Conclusions
Hypersensitivity reactions are generally much less com-
mon with non-ionic CM compared to older ionic CM.
However, for DHRs, reaction rates between ionic CM and
non-ionic CM are similar. Successful administration of dif-
ferent CM selected based on skin tests has been reported
for patients with previous DHRs to specific CM. In our
case, skin testing was non-diagnostic, and we hypothesized
that the distinct chemical structures of these agents would
make immunological cross-reactivity unlikely. Indeed this
patient who was repeatedly reactive to the non-ionic low-
osmolal CM ioxilan, subsequently tolerated the ionic
hyperosmolal CM iothalamate. We conclude that different
epitopes involved in DHRs to CM may be suggested based
on differing chemical structure and ionicity. Further
research is needed regarding both the cross-reactivity and
cross-tolerance of various CM in DHRs, especially in CM
skin-test negative patients.
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